Khalil Ansarin
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 2
-
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Saeid Safiri (6 shared papers)Ali Taghizadieh (5 shared papers)Seyed Aria Nejadghaderi (3 shared papers)Kristin Carson‐Chahhoud (3 shared papers)Ali‐Asghar Kolahi (3 shared papers)Mohammadreza Ardalan (4 shared papers)Mojtaba Varshochi (2 shared papers)Parviz Saleh (2 shared papers)
- Journals
- Reviews in Medical Virology (2 papers)Bioimpacts (1 paper)Advanced Pharmaceutical Bulletin (1 paper)International Journal of Clinical Practice (1 paper)Pharmacology Research & Perspectives (1 paper)
- Partner nations
- IranUnited StatesAustralia
In The Last Decade
Khalil Ansarin
11 papers receiving 243 citations
Peers
Comparison fields: 5 of 62
- Infectious Diseases 118
- Neurology 29
- Obstetrics and Gynecology 9
- Physiology 28
- Modeling and Simulation 5
Countries citing papers authored by Khalil Ansarin
This map shows the geographic impact of Khalil Ansarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Ansarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Ansarin more than expected).
Fields of papers citing papers by Khalil Ansarin
This network shows the impact of papers produced by Khalil Ansarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Ansarin. The network helps show where Khalil Ansarin may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalil Ansarin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 74 | |
| 2 | 2021 | 53 | |
| 3 | 2021 | 46 | |
| 4 | 2021 | 26 | |
| 5 | 2022 | 13 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 4 | |
| 10 | Review of Exhaled Biomarkers in Different Pulmonary Diseases | 2013 | 3 |
| 11 | Comparison Study of Cyfra 21-1, Carcinoembryonic Antigen and Telomerase Activity between Non Small Cell and Small Cell Lung Cancer Patients | 2008 | 1 |
| 12 | 2022 | 0 |
About Khalil Ansarin
Khalil Ansarin is a scholar working on Infectious Diseases, Molecular Biology, Neurology, Physiology and Genetics, having authored 12 papers that have together received 247 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (2 papers), Asthma and respiratory diseases (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Retinal and Optic Conditions (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Infectious Diseases (118 citations), Neurology (29 citations), Obstetrics and Gynecology (9 citations), Physiology (28 citations) and Modeling and Simulation (5 citations). Khalil Ansarin has collaborated with scholars based in Iran, United States and Australia. Frequent co-authors include Saeid Safiri, Ali Taghizadieh, Seyed Aria Nejadghaderi, Kristin Carson‐Chahhoud, Ali‐Asghar Kolahi, Mohammadreza Ardalan, Mojtaba Varshochi, Parviz Saleh, Maryam Noori and Hamed Valizadeh. Their work appears in journals such as Reviews in Medical Virology, Bioimpacts, Advanced Pharmaceutical Bulletin, International Journal of Clinical Practice and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.